[ad_1]
"We think that a year from now, we will have a complete cure for cancer, it will be effective from the first day, last a few weeks and will not have any serious side effects, a much lower cost than most treatments on the market, "said researcher Dan Aridor, director of AEBi's board of directors, in an interview for the newspaper.
The potentially revolutionary anticancer compound is based on SoAP technology, which involves the incorporation of DNA from a certain protein. in a bacteriophage (virus infecting bacteria). This protein is then exposed on the surface of the host microorganism. As a result, researchers can use the proteins displayed by bacteriophages to track interactions with other proteins, with genetic material or with small molecules.
The idea, according to Aridor, according to The Jerusalem Post, is that the treatment is capable of targeting three targets or cancer cells at a time, making it more effective than the currently used drugs, which usually target a specific target and may be mutated and metastasized (multiplication).
uses a combination of various peptides to target each type of cancer cell at the same time, badociated with a peptide toxin capable of killing only the tumor. "We have ensured that the treatment is not affected by the mutations, the cancer cells could even mutate and the target receptors would eventually be eliminated," said researcher Ilan Morad, CEO of AEBi, also in conversation with the Israeli newspaper.
For now, the novelty has only been tested in guinea pigs and the next step is to pbad clinical trials on cancer patients. They have not informed when this will be done.
[ad_2]
Source link